Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 27;10(9):1888.
doi: 10.3390/jcm10091888.

The Comparison of Outcomes of Transvaginal Mesh Surgery with and without Midline Fascial Plication for the Treatment of Anterior Vaginal Prolapse: A Randomized Controlled Trial

Affiliations

The Comparison of Outcomes of Transvaginal Mesh Surgery with and without Midline Fascial Plication for the Treatment of Anterior Vaginal Prolapse: A Randomized Controlled Trial

Ching-Hsiang Chiang et al. J Clin Med. .

Abstract

The aim of this study was to compare the clinical outcomes of transvaginal mesh (TVM) surgery with and without midline fascial plication for anterior prolapse repair. This is a prospective randomized trial in a teaching hospital. This study compared patients with anterior vaginal wall prolapse (POP-Q Ba > -1) who were randomly assigned to either transvaginal mesh (TVM, Avaulta SoloTM, CR Bard. Inc., Covington, GA, USA polypropylene mesh delivery system) (group A, n = 32) or TVM with concomitant midline fascial plication (group B, n = 32). The outcomes of anatomy correction and life quality were evaluated using a pelvic organ prolapse quantification system and questionnaires. Sixty-four patients were included from January 2011 through April 2014 in this study. Group A had a mean age of 63.7 years and a body mass index (BMI) of 25.4 kg/m2. Group B had a mean age of 62.9 years and a BMI of 25.4. The mean follow-up duration was 18.6 months (range 12-50). At the 12-month follow-up, anatomic recurrence was higher in Group A (5/31, 16.1%) than in Group B (1/30, 3.3%) but without statistical significance (p = 0.19). Improvements in symptoms and quality of life were not significantly different between the two groups. Mesh extrusion was detected in three of 61 patients (4.9%): two from group A (6.7%) and one from Group B (3.2%). TVM with concomitant midline fascia repair for anterior vaginal prolapse had a comparable anterior support and mesh exposure rate compared with TVM alone. Trial Registration: IRB-B09904021.

Keywords: life quality; mesh; pelvic organ prolapse; plication.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
Study flow chart. TVM: transvaginal mesh.

References

    1. Cooper J., Annappa M., Dracocardos D., Cooper W., Muller S., Mallen C. Prevalence of genital prolapse symptoms in primary care: A cross-sectional survey. Int. Urogynecol. J. 2015;26:505–510. doi: 10.1007/s00192-014-2556-x. - DOI - PubMed
    1. Wu J.M., Matthews C.A., Conover M.M., Pate V., Jonsson Funk M. Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet. Gynecol. 2014;123:1201–1206. doi: 10.1097/AOG.0000000000000286. - DOI - PMC - PubMed
    1. Smith F.J., Holman C.D.J., Moorin R.E., Tsokos N. Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet. Gynecol. 2010;116:1096–1100. doi: 10.1097/AOG.0b013e3181f73729. - DOI - PubMed
    1. Digesu G.A., Khullar V., Cardozo L., Robinson D., Salvatore S. P-QOL: A validated questionnaire to assess the symptoms and quality of life of women with urogenital prolapse. Int. Urogynecol. J. Pelvic Floor Dysfunct. 2005;16:176–181. doi: 10.1007/s00192-004-1225-x. - DOI - PubMed
    1. Barber M.D., Maher C. Epidemiology and outcome assessment of pelvic organ prolapse. Int. Urogynecol. J. 2013;24:1783–1790. doi: 10.1007/s00192-013-2169-9. - DOI - PubMed

LinkOut - more resources